Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Design Therapeutics, Inc. (DSGN) had Current Ratio of 25.13 for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
-- |
|
$-19.08M |
|
-- |
|
-- |
|
$21.57M |
|
$-21.57M |
|
$2.49M |
|
$-19.08M |
|
$-19.08M |
|
$-19.08M |
|
$-19.08M |
|
$-19.08M |
|
$-19.08M |
|
$-21.57M |
|
$-22.33M |
|
56.86M |
|
56.86M |
|
$-0.34 |
|
$-0.34 |
|
Balance Sheet Financials | |
$219.79M |
|
$1.26M |
|
$3.09M |
|
$222.89M |
|
$8.75M |
|
-- |
|
$1.10M |
|
$9.85M |
|
$213.04M |
|
$213.04M |
|
$213.04M |
|
56.95M |
|
Cash Flow Statement Financials | |
$-31.23M |
|
$27.99M |
|
$0.38M |
|
$22.56M |
|
$19.70M |
|
$-2.86M |
|
$7.52M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
Current Ratio |
25.13 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.96% |
|
-8.96% |
|
-8.56% |
|
-8.96% |
|
$3.74 |
|
$-0.55 |
|
$-0.55 |